Invention Grant
- Patent Title: α,β-unsaturated amide compound
-
Application No.: US17034604Application Date: 2020-09-28
-
Publication No.: US11332455B2Publication Date: 2022-05-17
- Inventor: Tomohiro Danjo , Katsuaki Fujiwara , Tomoyuki Nishikawa , Takahiro Nakajima , Nobumasa Otsubo , Toshihiro Seike
- Applicant: KYOWA KIRIN CO., LTD.
- Applicant Address: JP Tokyo
- Assignee: KYOWA KIRIN CO., LTD.
- Current Assignee: KYOWA KIRIN CO., LTD.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2015-252234 20151224
- Main IPC: C07D311/68
- IPC: C07D311/68 ; C07D401/04 ; C07D405/12 ; C07D311/74 ; A61K31/5377 ; A61K31/353 ; C07D215/38 ; A61K31/4433 ; A61K31/4709 ; A61K31/47 ; C07D213/74 ; C07D213/75 ; C07D215/24 ; C07D401/12

Abstract:
The present invention provides an α,β-unsaturated amide compound or a pharmaceutically acceptable salt or the like thereof having anticancer activity and the like represented by the following formula (I): [wherein, “A” represents optionally substituted heterocyclic diyl, R1 represents hydrogen atom or optionally substituted lower alkyl, R2 represents optionally substituted aryl, optionally substituted cycloalkyl, optionally substituted aliphatic heterocyclic group or optionally substituted aromatic heterocyclic group, X represents —O—, —S—, —SO2—, —NRX1— (wherein, RX1 represents hydrogen atom or lower alkyl), —CHRX2— (wherein, RX2 represents hydrogen atom or hydroxy), —CH═CH—, —CO— or —NH—CO—, and n1 and n2 are the same or different, and each represents 0 or 1].
Public/Granted literature
- US20210380551A1 ALPHA,BETA-UNSATURATED AMIDE COMPOUND Public/Granted day:2021-12-09
Information query